NDA 8843, held by Gd Searle LLC. Propantheline Bromide.
As of Nov 14, 2026, NDA 8843 (Pro-Banthine), held by Gd Searle LLC, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Pro-Banthine30MG/VIAL ยท injectable;injection | Propantheline Bromide | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters